Zhende Medical Soars 5.32%, Hits Intraday High of CNY 91.56

Zhende Medical Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock performance, gaining 5.32% on March 10, 2026. The stock reached an intraday high of CNY 91.56, reflecting its strong market activity for the day. In terms of performance metrics, Zhende Medical has outperformed the China Shanghai Composite index across various time frames. Over the past year, the stock has surged by an impressive 329.67%, while the Shanghai Composite has only seen a 22.49% increase. Year-to-date, Zhende Medical has also shown robust growth of 29.82%, compared to the index's 3.89%. Despite these positive short-term trends, the company faces challenges with long-term growth, as evidenced by a decline in net sales and operating profit over the past five years. The current market capitalization stands at CNY 19,569 million, and the stock features a price-to-earnings ratio of 31.00. With a dividend yield of 0.89%, Zhende Medical continues to navigate a complex financial landscape while showcasing notable daily performance.